clinical trial · NCT07109375
Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting
Chiesi Italia·—·not yet recruiting·n = 75
Fabry Diseasepegunigalsidase alfa
brief summary
PEGASO is an observational study designed to collect prospective data on the effectiveness and safety of pegunigalsidase alfa in adult patients with Fabry disease, being treated or planning to start treatment, under real-world setting.
started
Apr 1, 2026
primary completion
Dec 1, 2028
completion
Dec 1, 2028
last updated
Feb 24, 2026
official title
Observational Prospective Cohort Study on Long-term Effective and Safe Use of Pegunigalsidase Alfa in Adult Fabry Patients Under "Real-world" Setting
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol